Cargando…
Case Report: Propranolol increases the therapeutic response to temozolomide in a patient with metastatic paraganglioma
This case report presents the clinical evolution and management of a patient with a hereditary paraganglioma syndrome. This disease is characterized by rare tumors of neural crest origin that are symmetrically distributed along the paravertebral axis from the base of the skull and neck to the pelvis...
Autores principales: | Díaz-Castellanos, Miguel-Angel, Gómez de las Heras, Karina Villar, Díaz-Redondo, Tamara, González-Flores, Encarnación, Albiñana, Virginia, Botella, Luisa-María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824325/ https://www.ncbi.nlm.nih.gov/pubmed/29527294 http://dx.doi.org/10.12688/f1000research.13185.1 |
Ejemplares similares
-
Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease
por: Albiñana, Virginia, et al.
Publicado: (2017) -
Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients
por: Albiñana, Virginia, et al.
Publicado: (2015) -
Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial
por: González-Rodríguez, Beatriz, et al.
Publicado: (2019) -
The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases
por: Cuesta, Angel M., et al.
Publicado: (2022) -
Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
por: Albiñana, Virginia, et al.
Publicado: (2022)